ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-escalation Study of the Safety, Tolerability and Ability of CMX001 to Prevent or Control Cytomegalovirus (CMV) Infection in R+ Hematopoietic Stem Cell Transplant Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00942305
Recruitment Status : Completed
First Posted : July 20, 2009
Last Update Posted : January 18, 2012
Sponsor:
Information provided by:
Chimerix